Editorial: Cancer Treatment and Early Detection Targeting HER Receptors

Front Mol Biosci. 2022 Jun 15:9:940055. doi: 10.3389/fmolb.2022.940055. eCollection 2022.

Authors

Xiaoqing Cai¹, Libing Zhang², Shengxi Chen³

Affiliations

¹ School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.
² Tianjin Key Laboratory of Molecular Optoelectronic, Department of Chemistry, Tianjin University, Tianjin, China.
³ Biodesign Center for Bioenergetics, Arizona State University, Tempe, AZ, United States.

No abstract available

Keywords: EGFR; HER family; HER2; HER3; cancer targeted therapy.

Publication types

Editorial